Clinical Trial Update: A Trial of PEHRG214 in HIV-Infected Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of PEHRG214 in HIV-infected patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PEHRG214

Snippet

Sponsor: Virionyx Corporation Limited | Conditions: HIV Infections | Phase 2 | Status: TERMINATED